Turkey: Life Sciences, Biotechnology & Nanotechnology

Turkey's Pharmaceutical and Medical Devices Agency has published new guidelines establishing comprehensive naming standards for medicinal products, introducing systematic evaluation criteria and procedures for assessing name similarity and acceptability. The guidelines implement a scoring system through TIBAS that compares proposed names against existing databases, while also addressing international nonproprietary name conflicts and promotional language restrictions.

Turkish authorities and professional organizations have intensified their oversight of counterfeit and illegally traded health products, revealing persistent challenges in product availability and supply chain integrity.

Clinical trials are scientific studies conducted within the framework of specific ethical and legal rules in order to demonstrate the safety and efficacy of a medicinal product.